Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
RX Savings Solutions sale would see the startup acquired for up to $875M in KC’s biggest-ever exit
The McKesson Corporation has agreed to purchase Overland Park-prescribed Rx Savings Solutions in a deal worth nearly $1 billion. McKesson announced Monday that it had entered into an agreement with the prescription pricing startup valued at up to $875 million — more than double the $425 million price tag for which Kansas City-built Backlot Cars…
KC team developing tool to get low-income entrepreneurs online (and it just got a $240K boost)
A collaborative project to “bridge the gap” in Kansas City’s digital divide secured one of the 2022 Heartland Challenge grants from the Ewing Marion Kauffman Foundation. PCs for People Kansas City (formerly Connecting for Good), in partnership with The Usher Garage and No-Where Consultants, will receive $240,000 in funding to be used over two years…
How this KC trucking platform is helping drivers achieve the ‘American Dream’ amid high industry demands, burnout
The COVID-19 pandemic highlighted the importance of truck drivers in the American economy, said Jeff Dema; and Foxpoint is targeting its efforts to ensure that drivers succeed and stay in the demanding industry. “Being a truck driver is a hard job. They’re gone 250 plus nights a year from their home. It requires lots of…
Google’s $100K ‘stamp of approval’ for PlaBook reads like validation for KC-built edtech startup
Kansas City expatriate PlaBook is set to receive $100,000 from Google’s initiative to provide funding to Black-led startups. But for Philip Hickman, it’s not just about the funding, he said. It’s also a credibility boost. “We were happy to receive an investment from Google,” the edtech startup founder said. “It’s a stamp of approval to…